Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital

Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital

Background: Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been approved recently, and public concern regarding the risk of anaphylactic reactions arose after a few cases during the first days of mass vaccination. Polyethylene glycol (PEG) has been suggested as the...

Full description

Bibliographic Details
Main Authors: Giovanni Paoletti, Francesca Racca, Alessandra Piona, Giulio Melone, Morena Merigo, Francesca Puggioni, Sebastian Ferri, Elena Azzolini, Michele Lagioia, Donatella Lamacchia, Giuseppe Cataldo, Maurizio Cecconi, Giorgio Walter Canonica, Enrico Heffler
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:World Allergy Organization Journal
Subjects:
Allergy
Anaphylaxis
COVID-19
Polyethylen glycole
Vaccine
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455121000351

Internet

http://www.sciencedirect.com/science/article/pii/S1939455121000351

Similar Items